A pilot study of topiramate dosages for migraine prophylaxis in an Asian population

Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cos...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Y. L., Lum, S. Y., Fook-Chong, S., Siow, H. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2010
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452284/
https://www.ncbi.nlm.nih.gov/pubmed/20143246
http://dx.doi.org/10.1007/s10194-010-0193-4
_version_ 1782244459025530880
author Lo, Y. L.
Lum, S. Y.
Fook-Chong, S.
Siow, H. C.
author_facet Lo, Y. L.
Lum, S. Y.
Fook-Chong, S.
Siow, H. C.
author_sort Lo, Y. L.
collection PubMed
description Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.
format Online
Article
Text
id pubmed-3452284
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-34522842012-11-29 A pilot study of topiramate dosages for migraine prophylaxis in an Asian population Lo, Y. L. Lum, S. Y. Fook-Chong, S. Siow, H. C. J Headache Pain Brief Report Topiramate is known to be efficacious in migraine prophylaxis, but its optimal dose has not been systematically studied in the Asian population. Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile. Springer Milan 2010-02-09 2010-04 /pmc/articles/PMC3452284/ /pubmed/20143246 http://dx.doi.org/10.1007/s10194-010-0193-4 Text en © Springer-Verlag 2010
spellingShingle Brief Report
Lo, Y. L.
Lum, S. Y.
Fook-Chong, S.
Siow, H. C.
A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
title A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
title_full A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
title_fullStr A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
title_full_unstemmed A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
title_short A pilot study of topiramate dosages for migraine prophylaxis in an Asian population
title_sort pilot study of topiramate dosages for migraine prophylaxis in an asian population
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452284/
https://www.ncbi.nlm.nih.gov/pubmed/20143246
http://dx.doi.org/10.1007/s10194-010-0193-4
work_keys_str_mv AT loyl apilotstudyoftopiramatedosagesformigraineprophylaxisinanasianpopulation
AT lumsy apilotstudyoftopiramatedosagesformigraineprophylaxisinanasianpopulation
AT fookchongs apilotstudyoftopiramatedosagesformigraineprophylaxisinanasianpopulation
AT siowhc apilotstudyoftopiramatedosagesformigraineprophylaxisinanasianpopulation
AT loyl pilotstudyoftopiramatedosagesformigraineprophylaxisinanasianpopulation
AT lumsy pilotstudyoftopiramatedosagesformigraineprophylaxisinanasianpopulation
AT fookchongs pilotstudyoftopiramatedosagesformigraineprophylaxisinanasianpopulation
AT siowhc pilotstudyoftopiramatedosagesformigraineprophylaxisinanasianpopulation

Ejemplares similares